Drug Pipeline

JNJ-78934804 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
2
Phase 3
1
Top Sponsors
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-09 NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative…		 Recruitment opened
2026-06-09 NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative…		 Trial sites expanded: 0 -> 6 locations
2026-06-09 NCT07577843
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease		 Recruitment opened
2026-06-09 NCT07577843
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease		 Trial sites expanded: 0 -> 5 locations
Active Studies by Phase
Phase 3
2
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07577843 A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease Crohn Disease Recruiting
NCT07577856 A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative… Colitis, Ulcerative Recruiting
Phase 2
NCT05242471 A Study of Combination Therapy With Guselkumab and Golimumab in Participants With… Crohn's Disease Active, Not Recruiting
NCT05242484 A Study of Combination Therapy With Guselkumab and Golimumab in Participants With… Colitis, Ulcerative Active, Not Recruiting
Sponsors Running JNJ-78934804 Trials
Janssen Research & Development, LLC (4)
Disease Areas
Crohn's Disease (2)
Get alerts when JNJ-78934804 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free